ArticleCase reports in endocrinology2025
Recurrent Nausea and Hyponatraemia: Unmasking SIADH in a 50-Year-Old Woman.
Article in Case reports in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Syndrome of inappropriate antidiuretic hormone (SIADH) is a common cause of hyponatraemia that requires systematic investigation to identify underlying aetiologies. Central nervous system disorders represent an important but often underrecognised cause, particularly when patients present with non-specific gastrointestinal symptoms. Case Presentation: A 50-year-old woman presented with a 3-year history of intermittent nausea and vomiting that worsened over 20 days. Laboratory investigations revealed persistent hyponatraemia (serum sodium 125.4 mmol/L), low plasma osmolality (268.58 mOsm/kg H Management and Outcome: The patient was diagnosed with SIADH secondary to intracranial pathology. Treatment with fluid restriction (500-1000 mL/day) and oral salt supplementation (gradually increased to 2.5 g/day) successfully increased serum sodium to 130 mmol/L. Neurosurgical consultation recommended conservative management given the likely congenital developmental abnormalities. After 3 years of follow-up, the patient remains clinically stable with ongoing monitoring. Recent urine osmolality testing (611 mOsm/kg H Learning Points: This case demonstrates the importance of neuroimaging in unexplained SIADH and highlights practical diagnostic strategies when standard laboratory parameters like urine osmolality are unavailable. Central nervous system abnormalities should be systematically investigated in patients with persistent hyponatraemia and non-specific symptoms. Conservative management with fluid restriction and salt supplementation can be effective for mild-to-moderate SIADH cases.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.